Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14225
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, GLP-1 receptor agonists, insulin pump therapy, intensive insulin therapy, adjunctive therapy, glycemic control, HbA1c, body weight, hypoglycemia, gastrointestinal adverse effects, quality of life, drug safety, subcutaneous insulin injection, postprandial blood glucose
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W3092124082
